Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide.
| Product ID | 13668-386_7b2f628e-b066-47f3-b5da-d6987ef76a29 |
| NDC | 13668-386 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg |
| Generic Name | Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet 40/5/12.5 Mg |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-10-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203580 |
| Labeler Name | TORRENT PHARMACEUTICALS LIMITED |
| Substance Name | OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 40 mg/1; mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |